XML 28 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:        
Net loss $ (84,693) $ (57,693) $ (79,540) $ (74,407)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 3,197 4,169 5,502 6,037
Stock-based compensation 19,500 4,049 6,322 5,897
Change in fair value of derivative and warrant liability 606 3,791 4,920 1,846
Amortization of debt issuance cost 2,237 2,953 4,746 1,068
Non-cash lease amortization 2,168 2,412 3,586
Deferred income taxes 1,035    
Loss upon extinguishment of debt     3,775
Deferred taxes     113 (2,282)
Changes in operating assets and liabilities:        
Accounts receivable, net (729) (2,061) 1,515 (1,890)
Prepaid expenses (2,498) (75)    
Other current assets 2 (552)    
Contract assets (6,176)    
Prepaid expenses and other current assets     (1,085) (320)
Operating lease liabilities (3,085) (2,710) (3,565)
Other assets 46 (222) (1,470)
Accounts payable 398 (32) 424 1,174
Accrued liabilities 1,440 1,724 3,671 1,291
Deferred rent     640
Deferred revenue (6,815) (7,138) (10,281) 10,341
Other liabilities 797 (747) (1,035) 526
Net cash used in operating activities (73,605) (51,097) (66,177) (46,304)
Cash flows from investing activities:        
Purchases of property and equipment (1,188) (234) (636) (2,162)
Maturities of short-term investments     13,610
Net cash used in investing activities (1,188) (234) (636) 11,448
Cash flows from financing activities:        
Proceeds from issuance of convertible notes, net of issuance cost 5,044 14,905 40,000
Proceeds from note payable, net of issuance cost 29,833 29,833
Proceeds from issuance of preferred stock     16,000
Proceeds from the issuance of common stock upon exercise of options 3,620 1,906 2,490 254
Proceeds from Business Combination and PIPE, net of transaction costs 90,689    
Payments on notes payable (7,450)    
Payments on finance leases (1,246) (1,885)    
Payment of finance and capital lease obligations     (2,575) (3,000)
Proceeds from the exercise of warrants for redeemable convertible preferred stock     200
Net cash provided by financing activities 85,613 34,898 44,653 53,454
Net change in cash, cash equivalents, and restricted cash equivalents 10,820 (16,433) (22,160) 18,598
Cash, cash equivalents, and restricted cash equivalents, beginning of period 22,822 44,982 44,982 26,384
Cash, cash equivalents, and restricted cash equivalents, end of period 33,642 28,549 22,822 44,982
Reconciliation to amounts on the condensed consolidated balance sheets:        
Cash and cash equivalents 33,412 27,259 21,626 43,692
Current portion of restricted cash equivalents 230 460 230
Non-current portion of restricted cash equivalents 230 1,060 736 1,060
Total cash, cash equivalents, and restricted cash equivalents shown in the condensed consolidated statements of cash flows 33,642 28,549 22,822 44,982
Supplemental disclosures of cash flow information:        
Cash paid for interest 2,302 1,475 2,631 412
Cash paid for income taxes 787 260 234 738
Noncash investing and financing activities        
Operating lease liabilities and right-of-use assets through adoption of ASC 842 11,428 11,428
Conversion of convertible note into common stock pursuant to Business Combination 20,239    
Conversion of redeemable convertible preferred stock to common stock pursuant to Business Combination 279,503    
Operating lease liabilities arising from obtaining right-of-use assets 650 3,422 3,422
Property and equipment acquired under finance leases or debt 650    
Property and equipment acquired under capital leases or debt     584 257
Debt discount through issuance of common stock warrants $ 3,842 3,843
Debt discount through issuance of convertible note with derivative liability     6,520
Extinguishment of derivative liability     (5,377)
Non-cash debt discount     525
Issues of series C redeemable convertible preferred stock for exercise of warrants     5,816
Issues of series B redeemable convertible preferred stock for exercise of warrants     1,931
Deemed dividend from exchange of series D-3A redeemable convertible preferred stock for series D-3     3,182
Conversion of convertible notes to series D-3A redeemable convertible preferred stock     $ 30,664